Brief: Lansen Pharmaceutical Says Interim Results Expected To Exceed Profit Attributable As Compared With That In Same Period Last Year
14/06/2022 16:15
June 14 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* INTERIM RESULTS EXPECTED TO EXCEED PROFIT ATTRIBUTABLE AS
COMPARED WITH THAT IN SAME PERIOD LAST YEAR
* EXPECTED RESULTS ON RESUMPTION OF DEFERRED SALES AND
MARKETING
ACTIVITIES, SELLING AND MARKETING EXPENSES WOULD INCREASE
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year